Search research articles
Contact Us
Filters
Showing results (581-590 of 643) with videos related to
Page
of 65
Sort By:
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer
Hey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology
|
July 4, 2025
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer
Hey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Cancer Cell
|
October 21, 2022
A path to translation: How 3D patient tumor avatars enable next generation precision oncology
Shree Bose, Margarida Barroso, Milan G Chheda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2017
Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of <i>KRAS</i> Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers
Takeo Fujii, Afsaneh Barzi, Andrea Sartore-Bianchi, et al.
Future Oncology (London, England)
|
June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Research Square
|
February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumors
Nejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Breast Cancer Research : BCR
|
July 7, 2019
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
Yan Xing, Nancy U Lin, Matthew A Maurer, et al.
NPJ Breast Cancer
|
April 17, 2021
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
Lillian M Smyth, Gerald Batist, Funda Meric-Bernstam, et al.
Page
of 65
Search research articles
Search
Showing results (581-590 of 643) with videos related to
Sort By:
Page
of 65
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer
Hey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology
|
July 4, 2025
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer
Hey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Cancer Cell
|
October 21, 2022
A path to translation: How 3D patient tumor avatars enable next generation precision oncology
Shree Bose, Margarida Barroso, Milan G Chheda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2017
Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of <i>KRAS</i> Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers
Takeo Fujii, Afsaneh Barzi, Andrea Sartore-Bianchi, et al.
Future Oncology (London, England)
|
June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Research Square
|
February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumors
Nejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Breast Cancer Research : BCR
|
July 7, 2019
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
Yan Xing, Nancy U Lin, Matthew A Maurer, et al.
NPJ Breast Cancer
|
April 17, 2021
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
Lillian M Smyth, Gerald Batist, Funda Meric-Bernstam, et al.
Page
of 65